Cancer Treatments
Showing 1 - 25 of >10,000
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Recruiting
- Cancer
- +9 more
-
Edmonton, Alberta, CanadaEdith Pituskin
Nov 30, 2022
Responsiveness in Oncology Patients Based on Host Response
Recruiting
- Non Small Cell Lung Cancer
- Healthy
- blood, stool and tissue samples collection
-
Dallas, TexasBaylor Scott and White Research Institute
Feb 9, 2023
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
- Melanoma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 6, 2023
Sexual Functioning Trial in London (Mindful compassion based on behavioural change taxonomy experimental group)
Completed
- Sexual Functioning
- Mindful compassion based on behavioural change taxonomy experimental group
-
London, United KingdomLondon Met university
Sep 14, 2023
Colorectal Cancer Stage IV Trial in Sherbrooke (Resting state (Control), Moderate Intensity Continuous Exercise (MICE), High
Recruiting
- Colorectal Cancer Stage IV
- Resting state (Control)
- +2 more
-
Sherbrooke, Quebec, CanadaResearch Centre on Aging
May 16, 2022
Refractory Cancer, Relapsed Cancer Trial in Weston (Drug Sensitivity Test (DST))
Not yet recruiting
- Refractory Cancer
- Relapsed Cancer
- Drug Sensitivity Test (DST)
-
Weston, FloridaLerner College of Medicine: Cleveland Clinic Florida
Sep 1, 2023
Appropriate Dosing to Optimise Personalised Cancer Treatments
Completed
- Melanoma Stage III
- +5 more
- Dried blood Spot (DBS)
- Venous blood sampling
-
Dundee, Scotland, United KingdomNHS Tayside and University of Dundee
Feb 25, 2022
Breast Cancer Trial in Caen (Cognitive stimulation sessions coupled with Adapted Physical Activity sessions.)
Completed
- Breast Cancer
- Cognitive stimulation sessions coupled with Adapted Physical Activity sessions.
-
Caen, Francecentre François Baclesse
Mar 7, 2022
Long-term Arm Morbidity Following Breast Cancer Surgeries and
Recruiting
- Breast Cancer
-
Tel Aviv, IsraelAssuta medical center
Jul 17, 2023
ctDNA Predicts Recurrence of Advanced Ovarian Cancer After
Recruiting
- Ovarian Cancer Stage IV
- Ovarian Cancer Stage III
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital
Aug 30, 2023
s and Clinical Variables on Thyroid Cancer
Recruiting
- Thyroid Cancer
-
Milan, ItalyIstituto Auxologico Italiano, IRCCS
Mar 1, 2023
Colorectal Cancer, Resectable Colorectal Carcinoma Trial in Milan (Trastuzumab deruxtecan, Durvalumab, Panitumumab)
Active, not recruiting
- Colorectal Cancer
- Resectable Colorectal Carcinoma
- Trastuzumab deruxtecan
- +4 more
-
Milan, Lombardia/MI, ItalyFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 26, 2023
Distress, Emotional, Depression, Anxiety, Fatigue Trial in Boston (Individualized Evidence-Based Therapy in Cancer (Patients),
Not yet recruiting
- Distress, Emotional
- +4 more
- Individualized Evidence-Based Therapy in Cancer (Patients)
- Training in Individualized Evidence-Based Therapy in Cancer (Therapists)
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 6, 2023
Treatments of HPV-related Lesions
Not yet recruiting
- HPV
- +3 more
- LASER surgery
- (no location specified)
Jul 3, 2023
Antalgic Effects of Well-being Treatments in Cancer Care
Completed
- Cancer
- Cancer Pain
-
Valence, Drome, FranceCh Valence
Aug 5, 2022
Sarcopenia and Chemobrain in Post-cancer Patients
Active, not recruiting
- Cancer
- Sarcopenia
- Study of the adverse effects of long-term oncological treatments
- Study of the long-term side effects of oncological treatments on the anxiety-depressive and cognitive state of patients
-
Pierre-Bénite, FranceService de Rhumatologie, Hospices Civils de Lyon, Groupement Hos
Mar 24, 2023
Breast Cancer Trial in Ann Arbor (Breast cancer decision aid)
Recruiting
- Breast Cancer
- Breast cancer decision aid
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Aug 31, 2022
Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for
Not yet recruiting
- Carcinoma
- +7 more
- XNW5004
- Pembrolizumab 25 mg/mL Solution for Injection
- (no location specified)
Aug 31, 2023
Hepatocellular Carcinoma, Chronic Hepatitis B Trial in Xiamen (NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined
Recruiting
- Hepatocellular Carcinoma
- Chronic Hepatitis B
- NAs（"Entecavir"or"Tenofovir"or"Tenofovir alafenamide"） combined with interferon treatments
- NAs （"Entecavir"or"Tenofovir"or"Tenofovir alafenamide"） treatments
-
Xiamen, Fujian, ChinaBoheng Zhang
Feb 7, 2023
Prostate Cancer, Cancer of Prostate, Prostate Adenocarcinoma Trial (Stereotactic Ablative Body Radiation)
Not yet recruiting
- Prostate Cancer
- +2 more
- Stereotactic Ablative Body Radiation
- (no location specified)
Oct 26, 2022
NSCLC, Advanced Cancer Trial in France (Usual care, Optimization of the medical decision)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Advanced Cancer
- Usual care
- Optimization of the medical decision
-
Abbeville, France
- +24 more
Aug 19, 2022
Thoracic Cancer, Pancreatic Cancer Non-resectable, Brain Cancer Trial (Proton Radiation)
Not yet recruiting
- Thoracic Cancer
- +4 more
- Proton Radiation
- (no location specified)
Sep 19, 2022
Learn More About Order of Different Treatments and Their Effects
Not yet recruiting
- Metastatic Colorectal Cancer
- Regorafenib (Stivarga, BAY73-4506)
- (no location specified)
Nov 13, 2023
